![]() |
市场调查报告书
商品编码
1716322
2032 年兽医诊断市场预测:按产品、动物类型、技术、最终用户和地区进行的全球分析Veterinary Diagnostics Market Forecasts to 2032 - Global Analysis By Product (Instruments and Consumables), Animal Type, Technology, End User and By Geography |
根据 Stratistics MRC 的数据,全球兽医诊断市场预计在 2025 年达到 40 亿美元,到 2032 年将达到 74 亿美元,预测期内的复合年增长率为 9.1%。
用于确定动物的疾病、状况和整体健康状况的方法和仪器称为兽医诊断。它包括影像、分子诊断和实验室测试,帮助兽医识别感染疾病、基因异常和其他健康问题。这些诊断对于提供有效的治疗、疾病预防和动物福利至关重要。兽医诊断可实现早期和准确的诊断,从而有助于牲畜管理和伴同性动物护理,有利于食品安全、公共卫生和全球动物保健部门。
根据美国宠物产品协会(APPA)2023年至2024年的调查显示,美国约有66%的家庭拥有至少一隻宠物,总数约8,690万户。
宠物拥有量和支出成长
随着越来越多的家庭将宠物视为家庭的一部分,他们在宠物健康和福利上花费的钱也在增加。这一趋势是由对先进诊断设备的需求推动的,以确保快速且准确的疾病诊断。越来越多的饲主开始投资定期检查和预防性护理。因此,医院和兽医诊所正在部署先进的诊断工具。由于这种需求的不断增长,兽医诊断市场正在不断增长。
诊断设备高成本
对于许多兽医诊所,特别是农村和开发中地区的兽医诊所来说,先进的诊断设备是遥不可及的。这限制了他们提供快速准确诊断的能力。这会导致治疗延迟或无效,对动物保健产生负面影响。高昂的设备成本也可能阻碍对现代诊断技术的投资。这将减缓市场成长,尤其是对于中小型兽医服务供应商。
远端医疗和远距离诊断
这项技术使兽医能够远端咨询、诊断和监控宠物和牲畜。因此,宠物饲主和农场主人节省了金钱和旅行时间,顾客也变得更加满意和顺从。行动成像设备和穿戴式健康监测器是远距离诊断技术的例子,它们可以提供即时数据以进行准确评估。远端医疗的有效性和便利性也有利于更早发现疾病并更频繁地进行身体检查。因此,对专门用于虚拟兽医护理的设备和诊断服务的需求日益增长。
通用感染疾病处理不当的风险
缺乏对通用感染疾病的有效应对会破坏人们对兽医卫生系统的信任,并阻碍对诊断的投资。应对不充分或延迟可能会导致疾病传播失控,并增加人类和动物的死亡率。这反过来又破坏了政府和公众对目前兽医基础设施的信心。恐慌和经济混乱常常导致人们的注意力从预防性诊断转向紧急应变。监管机构可能会引入抑制创新和市场成长的限制措施。综合起来,无效的疫情管理将阻碍市场扩张并减少对尖端兽医诊断的需求。
COVID-19的影响
由于封锁、兽医就诊次数减少以及供应链问题,COVID-19 疫情最初扰乱了兽医诊断市场。然而,宠物拥有量的增加和人们对通用感染疾病认识的提高刺激了对诊断测试的需求。远端医疗和照护现场诊断的兴起刺激了该领域的创新。加强动物健康和疾病监测凸显了市场的弹性。总体而言,市场早期遭遇挫折,但随后强劲復苏,而对动物健康和公共的日益关注也支撑了长期成长。
预计设备部分将成为预测期内最大的部分
在预测期内,由于动物疾病的准确检测,仪器仪表领域预计将占据最大的市场占有率。由于分析和成像设备技术的发展,诊断的效率和可靠性得到了显着提高。这些工具有助于早期诊断,从而可以更快地进行治疗并改善动物的健康状况。牲畜和宠物饲养需求的不断增长进一步推动了诊断工具的使用。动物保健基础设施投资的增加也支持了市场的扩张。
预测期内尿液检查领域预计将达到最高复合年增长率
尿液检查领域能够早期发现动物的各种疾病和糖尿病,预计在预测期内将出现最高的成长率。我们透过提供快速、经济、非侵入性的诊断技术来改善兽医护理的结果。随着宠物拥有量的增加和动物健康知识的提高,对常规尿液检查的需求也日益增长。自动尿液分析仪的技术发展进一步简化了诊断过程并提高了准确性。这使得尿液检查对于预防性医疗保健至关重要,并有助于整个兽医诊断市场的发展。
在预测期内,由于宠物饲养量的增加、人们对动物健康的认识的提高以及畜牧业生产的扩大,预计亚太地区将占据最大的市场占有率。分子诊断和生物感测器等诊断技术的进步正在增强疾病的检测和管理。各国政府也在加大动物健康方面的力度,推动及时诊断的需求。中国、印度和日本等主要国家正在推动市场扩张,这得益于其不断增长的兽医基础设施以及针对这一充满活力地区的全球动物保健公司的投资。
在预测期内,由于人们对动物健康的认识不断提高以及诊断技术的进步,预计北美地区将呈现最高的复合年增长率。该地区受益于完善的兽医基础设施、高额的伴同性动物医疗保健支出以及日益增长的早期疾病检测需求。主要市场相关人员正在投资分子诊断和就地检验等创新诊断工具。畜牧业也以疾病控制和食品安全为重点,为市场扩张做出了贡献。美国在该地区占有最大的市场占有率。
According to Stratistics MRC, the Global Veterinary Diagnostics Market is accounted for $4.0 billion in 2025 and is expected to reach $7.4 billion by 2032 growing at a CAGR of 9.1% during the forecast period. The methods and equipment used to determine an animal's illness, condition, and general state of health are referred to as veterinary diagnostics. It consists of imaging, molecular diagnostics, and laboratory testing that assist veterinarians in identifying infections, genetic abnormalities, and other health problems. In order to provide efficient treatment, illness prevention, and animal welfare, these diagnostics are essential. Veterinary diagnostics help livestock management and companion animal care by facilitating early and accurate diagnosis, which benefits food safety, public health, and the global animal healthcare sector.
According to the American Pet Products Association (APPA) study conducted between 2023 and 2024, approximately 66% of households in the U.S. have at least one pet, totaling around 86.9 million households.
Growth in pet ownership and expenditure
The amount spent on pets' health and wellbeing has increased as more homes consider them members of the family. The need for sophisticated diagnostic instruments to guarantee prompt and precise illness diagnosis is fuelled by this trend. More and more pet owners are prepared to spend money on routine examinations and preventive care. As a result, hospitals and veterinary clinics are implementing advanced diagnostic tools. The market for veterinary diagnostics is growing as a direct result of this increase in demand.
High cost of diagnostic equipment
Advanced diagnostic equipment is out of reach for many veterinary clinics, particularly those in rural or developing areas. This restricts their capacity to provide prompt and precise diagnosis. As a result, delayed or ineffective therapies negatively impact animal healthcare. Investment in contemporary diagnostic methods is sometimes deterred by high equipment prices. This slows down market growth, especially for small and mid-sized veterinary service providers.
Telemedicine and remote diagnostics
Veterinarians can now consult, diagnose, and keep an eye on pets and livestock remotely thanks to this technology. Pet owners and farm managers save money and travel time as a result, increasing customer happiness and compliance. Mobile imaging equipment and wearable health monitors are examples of remote diagnostics technologies that offer real-time data for precise evaluations. Early disease detection and more frequent checkups are also encouraged by the effectiveness and convenience of telemedicine. Consequently, the need for instruments and diagnostic services specifically designed for virtual veterinarian care is increasing.
Risk of zoonotic outbreak mismanagement
Ineffective handling of zoonotic outbreaks erodes confidence in veterinary healthcare systems and discourages diagnostic investment. Inadequate or delayed reactions may result in unchecked disease transmission, raising both human and animal mortality. Government and public trust in the current veterinary infrastructure is damaged as a result. Focus frequently shifts from preventive diagnosis to emergency response as a result of the ensuing panic and economic upheaval. Regulations may be put in place by regulatory agencies that hinder innovation and market growth. All things considered, ineffective outbreak management stunts expansion and reduces demand for cutting-edge veterinary diagnostics.
Covid-19 Impact
The COVID-19 pandemic disrupted the veterinary diagnostics market initially due to lockdowns, reduced veterinary visits, and supply chain issues. However, increased pet adoption and growing awareness of zoonotic diseases fueled demand for diagnostic testing. Telemedicine and point-of-care diagnostics gained traction, driving innovation in the sector. Research on animal health and disease surveillance intensified, highlighting the market's resilience. Overall, while the market faced early setbacks, it rebounded strongly, with long-term growth supported by heightened focus on animal health and public safety.
The instruments segment is expected to be the largest during the forecast period
The instruments segment is expected to account for the largest market share during the forecast period, due to accurate disease detection in animals. The efficiency and dependability of diagnosis have been greatly increased by technological developments in analysers and imaging equipment. These tools facilitate early diagnosis, allowing for prompt treatment and better results for the health of the animals. The usage of diagnostic tools is further fuelled by increased livestock production demands and pet ownership. The expansion of this market is also supported by more investments in the infrastructure of veterinary healthcare.
The urinalysis segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the urinalysis segment is predicted to witness the highest growth rate, due to by enabling early detection of various diseases and diabetes in animals. It improves the effectiveness of veterinary care by providing a quick, affordable, and non-invasive diagnostic technique. The need for routine urine testing is being driven by rising pet ownership and greater knowledge of animal health. Further streamlining diagnostic processes and increasing accuracy are technological developments in automated urine analysers. Because of this, urinalysis is essential to preventative healthcare and helps the veterinary diagnostics market as a whole.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership, increasing awareness of animal health, and expanding livestock production. Advancements in diagnostic technologies, such as molecular diagnostics and biosensors, are enhancing disease detection and management. Governments are also strengthening animal health initiatives, boosting demand for timely diagnostics. Key countries like China, India, and Japan are driving market expansion, supported by growing veterinary infrastructure and investment from global animal health companies targeting this dynamic region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to rising awareness of animal health, and advancements in diagnostic technologies. The region benefits from well-established veterinary infrastructure, high healthcare expenditure on companion animals, and a growing demand for early disease detection. Key market players are investing in innovative diagnostic tools, including molecular diagnostics and point-of-care testing. The livestock sector also contributes to market expansion, with emphasis on disease control and food safety. The United States holds the largest market share in the region.
Key players in the market
Some of the key players profiled in the Veterinary Diagnostics Market include IDEXX Laboratories, Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific Inc., Avante Animal Health, Virbac, Randox Laboratories Ltd., VCA Animal Hospitals, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Antech Diagnostics, Inc., Agrolabo S.p.A., Embark Veterinary, Inc., Esaote SPA, Innovative Diagnostics SAS, FUJIFILM Corporation, Neogen Corporation, Bio-Rad Laboratories, Inc., INDICAL Bioscience GmbH
In February 2024, IDEXX enhanced VetConnect PLUS(R), enabling veterinarians to access reference lab sample turnaround times and order status information. Additionally, IDEXX DecisionIQ(TM), integrated within VetConnect PLUS(R), provides AI-driven clinical decision support for conditions like vector-borne diseases, chronic kidney disease, and endocrine disorders.
In August 2023, Zoetis launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic tool in several European markets. This product enables farmers and veterinarians to detect Gram-positive mastitis in cows within 8 hours, facilitating targeted antimicrobial therapy.
In January 2023, IDEXX launched a new diagnostic test for kidney injury in cats and dogs, enhancing its renal testing portfolio. This innovation helps veterinarians detect kidney damage earlier, improving treatment outcomes and advancing IDEXX's commitment to providing comprehensive, accurate diagnostic solutions for veterinary care.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.